ArticleNanomaterials (Basel, Switzerland)2019
A Novel Route to Manufacture 2D Layer MoS
Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 26 citations in OpenAlex.
- In Situ Construction of 2D/2D g-CNanomaterials (Basel, Switzerland) · 2025Article
- Electron-assisted synthesis of g-CRSC advances · 2020Article
- Noble Metal-Free TiONanomaterials (Basel, Switzerland) · 2020Article
- Sonochemical Synthesis of Copper-doped BiVONanomaterials (Basel, Switzerland) · 2020Article
- Plasma for Energy and Catalytic Nanomaterials.Nanomaterials (Basel, Switzerland) · 2020Article
- A Novel Au@CuNanomaterials (Basel, Switzerland) · 2019Article
- N-Doped Carbon-Coated ZnS with Sulfur-Vacancy Defect for Enhanced Photocatalytic Activity in the Visible Light Region.Nanomaterials (Basel, Switzerland) · 2019Article
- Enhanced Visible-Light Photocatalytic Activity of Ag QDs Anchored on CeONanomaterials (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
An atmospheric plasma treatment strategy was developed to prepare two-dimensional (2D) molybdenum disulfide (MoS
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.